MeSH tree: D20.215.894.899.085
Two major medical groups will begin reviewing vaccine safety and effectiveness after major changes at the U.S. Centers for Disease Control and Prevention (CDC) have raised alarms among experts.
5 hours ago
0
0
Six days after a senior FDA official sent a sweeping internal email claiming that COVID vaccines had caused the deaths of "at least 10 children," 12 former FDA commissioners released an extraordinary warning in the Dec. 3 ...
Dec 22, 2025
0
0
While life expectancy across the U.S. declined significantly during the COVID-19 pandemic, a new study led by researchers at the University of Hawaiʻi Thompson School of Social Work & Public Health and the Hawaiʻi State ...
Dec 15, 2025
0
0
The Food and Drug Administration's COVID-19 vaccine approval issued Aug. 27 comes with restrictions on who's eligible to receive the vaccine. Meanwhile, the administration has endorsed seasonal influenza vaccines—but only ...
Aug 29, 2025
0
0
For 30 years, vaccine recommendations from the Centers for Disease Control and Prevention have aligned closely with those from the American Academy of Pediatrics, or AAP. But on Aug. 19, 2025, the AAP published new vaccine ...
Aug 21, 2025
0
1
Lymph nodes are a key part of the human immune system, whose primary function is to combat infections. The effectiveness of vaccines is based on their ability to trigger events in lymph nodes that lead to the development ...
Aug 18, 2025
0
74
Moderna's COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration (FDA) for use in children with medical conditions that put them at higher risk of severe illness.
Jul 11, 2025
0
0
Major new analysis from the Thrombotic Thrombocytopenia Syndrome (TTS) Consortium has provided critical insights into the rare but serious condition known as vaccine-induced immune thrombotic thrombocytopenia (VITT).
Jul 8, 2025
0
0
Germany's BioNTech is buying domestic rival CureVac for $1.25 billion, the companies said Thursday, bringing together two pharmaceutical firms specialized in mRNA technology with the goal of advancing cancer treatments.
Jun 12, 2025
0
0
The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
Jun 4, 2025
0
3
